- High gross margin of 100.0%
- Lower volatility than the market (beta 0.33)
- Low bankruptcy risk (Altman Z-Score: 7.97)
Lexaria Bioscience Corp. stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session
(Updated on Jun 17, 2026)
The Lexaria Bioscience Corp. stock price gained 3.65% on the last trading day (Wednesday, 17th Jun 2026), rising from $0.589 to $0.611. During the last trading day the stock fluctuated 8.75% from a day low at $0.570 to a day high of $0.620. The price has been going up and down for this period, and there has been a -1.47% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 16 thousand more shares were traded than the day before. In total, 63 thousand shares were bought and sold for approximately $38.42 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.55% during the next 3 months and, with a 90% probability hold a price between $0.309 and $0.543 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
LEXX Signals & Forecast
There are mixed signals in the stock today. The Lexaria Bioscience Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.626 and $0.627. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Monday, May 18, 2026, and so far it has risen 9.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Lexaria Bioscience Corp. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Lexaria Bioscience Corp. stock
Lexaria Bioscience Corp. finds support from accumulated volume at $0.610 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0499 between high and low, or 8.75%. For the last week, the stock has had daily average volatility of 7.62%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LEXX) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect Lexaria Bioscience Corp. to open at $0.600, and during the day (based on 14 day Average True Range), to move between $0.585 and $0.636, which gives a possible trading interval of +/-$0.0515 (+/-8.82%) up or down from last closing price. If Lexaria Bioscience Corp. takes out the full calculated possible swing range there will be an estimated 8.82% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.610 (0.11%) than the resistance at $0.659 (7.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Lexaria Bioscience Corp. stock A Buy?
Lexaria Bioscience Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.152
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 18, 2026 - $0.600 ( 1.69%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LEXX Performance
Trading levels for LEXX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.650 | 6.49% |
| R2 | 0.631 | 3.36% |
| R1 | 0.619 | 1.44% |
| Price | 0.611 | |
| S1 | 0.581 | -4.81% |
| S2 | 0.569 | -6.74% |
| S3 | 0.550 | -9.86% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.750 | 22.92% |
| R2 | 0.689 | 12.84% |
| R1 | 0.659 | 7.94% |
| Price | 0.611 | |
| S1 | 0.610 | -0.115% |
| S2 | 0.602 | -1.33% |
| S3 | 0.577 | -5.52% |
FAQ
Click here for our free guide on how to buy Lexaria Bioscience Corp. Stock.
Buy LEXX